secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2024-09-30T23:59:59+00:00
Accession:  0001477932-24-006038
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx appoints Dr. Ethel Rubin as independent director; board expands to 7
-------------------------------------------------------------------------------

- Dr. Rubin appointed effective Sept 30, 2024; board increased from 6 to 7 members.
- She will serve on both the Audit Committee and the Compensation Committee.
- Compensation: $10,840 per quarter plus 15,000 RSUs vesting over 3 years.
- Dr. Rubin brings 20+ years life sciences experience; previously at Medtronic and BioHealth Innovation.
- She contributed to over 25 commercial products and multiple M&A, partnerships.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793224006038/0001477932-24-006038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793224006038/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-006038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer